Cited by 90Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Glucose metabolism, neural cell senescence and Alzheimer's disease

Open access
Wang, Qianqian, Duan, Linyan, Li, Xingfan, Wang, Yifu, Guo, Wenna, Guan, Fangxia, Ma, Shanshan·2022·International Journal of Molecular Sciences

Abstract

Alzheimer’s disease (AD), an elderly neurodegenerative disorder with a high incidence and progressive memory decline, is one of the most expensive, lethal, and burdening diseases. To date, the pathogenesis of AD has not been fully illustrated. Emerging studies have revealed that cellular senescence and abnormal glucose metabolism in the brain are the early hallmarks of AD. Moreover, cellular senescence and glucose metabolism disturbance in the brain of AD patients may precede amyloid-β deposition or Tau protein phosphorylation. Thus, metabolic reprogramming targeting senescent microglia and astrocytes may be a novel strategy for AD intervention and treatment. Here, we recapitulate the relationships between neural cell senescence and abnormal glucose metabolism (e.g., insulin signaling, glucose and lactate metabolism) in AD. We then discuss the potential perspective of metabolic reprogramming towards an AD intervention, providing a theoretical basis for the further exploration of the pathogenesis of and therapeutic approach toward AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23084351

Cites

170 of 170 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced insulin/PI3K signaling contributes to widespread proteomic synaptic and metabolic compromise in CA1/CA2, even when transcriptional changes in PI3K components are modest.

    “Although CA1 and CA2 did not show the largest changes in PIK3CA transcriptionally, each exhibited pronounced proteomic evidence of downstream pathway remodeling, suggesting that reduced insulin/PI3K signaling contributes to widespread proteomic synaptic and metabolic compromise in CA1/CA2, 42 , 66 , 67 even when transcriptional changes in PI3K components are modest.”

    From Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations (2026) · cites this paper as [67]

    Section 4.1 links impaired insulin/PI3K-AKT signaling to reduced glucose metabolism and impaired synaptic plasticity, supporting the proposed general mechanism. It does not establish proteomic compromise specifically in CA1/CA2 or relate it to modest transcriptional changes in PI3K components. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S.
Affiliations
Zhengzhou University (CN)
Corresponding author
  • Guan, Fangxia
  • Ma, Shanshan
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-04-14
Volume
23
Issue
8
Pages
4351
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4224072296
Cited by
90
References
170
Citations by year
2026: 18 · 2025: 22 · 2024: 23 · 2023: 23 · 2022: 4
FWCI
2.48
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (U2004201)
  • Central Plains Thousand People Plan of Henan Province (204200510013)
  • Henan Overseas Expertise Introduction Center for Discipline Innovation (CXJD2021002)
  • The Key Science and Technology Research Project of Henan Province of China (212102310175)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, cellular senescence, glucose metabolism, metabolic reprogramming, insulin signaling, lactate metabolism, amyloid-beta deposition, tau phosphorylation, neurodegeneration
MeSH terms
Aged, Alzheimer Disease, Brain, Glucose, Humans, Neurons, Amyloid beta-Peptides, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review